Alexander disease (AD) is an autosomal dominant progressive astrogliopathy caused by pathogenic variants in glial fibrillary acidic protein (GFAP).
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Clinical report
The patient is a 35-year-old woman with progressive left hemidystonia, retinitis pigmentosa (RP), and history of brain tumor. At age 8 years, she developed vision loss, limp, afferent pupillary defect, and optic disc edema. A pilocytic astrocytoma, World Health Organization grade I, was diagnosed and resected. At age 14 years, she developed gait abnormality and progressive left hemidystonia that responded well to botulinum toxin injections. She then developed bilateral optic disc fibrosis, bitemporal hemianopia, and bilateral posterior subcapsular cataracts and was diagnosed with RP at 22 years (figure, A-D). She also reported chronic constipation, functional megacolon, uterine leiomyomas, and dysphagia.
Family history includes nonconsanguineous unaffected parents. Physical examination showed relative macrocephaly, absent ocular horizontal and vertical pursuit, dysarthria, circumduction gait and left-sided arm dystonia, muscle atrophy, hyperreflexia, and ankle clonus. Brain MRI demonstrated a frontal resection cavity, cystic encephalomalacia, and fluctuating enhancement of the hypothalamus. At age 29 years, a new left middle cerebellar peduncle lesion was identified (figure, E and F).
The patient was enrolled in the NIH Undiagnosed Diseases Network (UDN). Whole-exome sequencing (WES) for her and her mother was completed. Her father was deceased at the time of evaluation. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
Results
WES revealed a novel heterozygous variant of uncertain significance (VUS) in GFAP (MIM_137780) c.989G>C (p.R330P, NM_002055) and a heterozygous VUS c.6196G>A (p.D2066N, NM_006269) in RP1 (MIM_603937), both absent in the mother. The parental origin of the GFAP mutated allele could not be concluded based on WES data and available DNA samples. The variant in RP1 was reported in 127 heterozygotes among 138,396 unrelated, unaffected individuals in gnomAD database (gnomad.broadinstitute.org). Both variants are predicted as damaging in SIFT (sorting intolerant from tolerant; sift.jcvi.org/) and Polyphen-2 (genetics.bwh. harvard.edu/pph2). No other contributory variants were detected in 256 known retinal disease genes.
Pathology slides from the initial brain mass were re-examined. Histologic examination showed features of AD, including profuse Rosenthal fiber formation, Rosenthal fiber-like eosinophilic cytoplasmic inclusions in astrocyte cell bodies, and scattered cells with markedly atypical nuclei (figure, G and H).
Discussion
Radiologic findings in AD vary with age at onset, and typical characteristics have been described for the various forms of AD. Serial radiologic imaging of our patient showed sequelae of right frontal lobe resection, development of periventricular white matter changes, and fluctuating brainstem and hypothalamic lesions. Waxing and waning imaging findings, in the absence of treatment, were inconsistent with a brain tumor. Therefore, despite her previous diagnosis of a brain tumor, these new findings were interpreted as non-neoplastic, and the working diagnosis was non-MS demyelinating lesions. Similar atypical MRI findings had been described before in patients with molecularly proven AD.
2 Dystonia and retinal abnormalities have never been previously reported with AD. Left hemidystonia in our patient may be secondary to ADrelated encephalomalacia or a possible delayed consequence of right frontal brain resection. 3 The RP1 VUS in our patient is less likely to be pathogenic, given the presence of multiple heterozygous carriers in population databases. It is unclear whether RP is a phenotypic expansion of AD or an unrelated finding (i.e., dual genetic diagnosis). 4 Several histologic features of AD can mimic brain tumors. Rosenthal fiber formation in astrocytes of the brain and spinal cord, a pathologic hallmark of AD, is also seen in several low-grade primary brain tumors (e.g., pilocytic astrocytoma, ganglioglioma, and pleomorphic xanthoastrocytoma). Cytologically atypical astrocytes, a recognized feature of AD, 5 can also lead to misdiagnosis of pilocytic astrocytoma/ganglioglioma and unnecessary invasive interventions. The presence of Rosenthal fiber-like eosinophilic cytoplasmic inclusions in astrocyte cell bodies serves as a "red flag," raising the index of suspicion of AD.
Over 120 pathogenic variants in GFAP have been reported with a possible dominant gain-of-function mechanism.
6 GFAP p.R330P substitutes arginine, located in the evolutionarily wellconserved structure of GFAP, with proline. Another change in the same amino acid, p.R330G, was associated previously with adult AD. 7 The potential functional significance of the p.R330P substitution, our patient's phenotype, and the histologic findings all strongly support GFAP p.R330P being a disease-causing variant.
Although relative macrocephaly, spasticity, ocular movement abnormalities, and autonomic disturbance (functional megacolon), as seen in our patient, have been described in juvenile AD, 1 the diagnosis of AD was delayed because of an atypical presentation, including RP, left hemidystonia, atypical MRI findings, and histologic features confounding the diagnosis. This case emphasizes the clinical, histologic, and radiologic challenges in diagnosing AD and demonstrates the importance of considering AD in the differential diagnosis of specific Rosenthal fiber-rich brain lesions such as pilocytic astrocytoma. 
